Literature DB >> 27556789

Metabolic Tumor Volume and Total Lesion Glycolysis in PET/CT Correlate With the Pathological Findings of Colorectal Cancer and Allow Its Accurate Staging.

Yoshiyuki Suzuki1, Koji Okabayashi, Hirotoshi Hasegawa, Masashi Tsuruta, Kohei Shigeta, Koji Murakami, Yuko Kitagawa.   

Abstract

INTRODUCTION: PET/CT plays an important role in cancer diagnosis. Recently, novel metabolic parameters in PET/CT such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG) have been reported to be diagnostic and prognostic biomarkers of various cancers. We evaluated the diagnostic value of these metabolic parameters in colorectal cancer (CRC).
METHODS: The study included 138 patients who underwent surgical resection of CRCs between August 2012 and March 2014. The MTVs and TLGs of tumors were measured using various SUV thresholds. The diagnostic abilities of the metabolic parameters were analyzed using ROC curves and classification and regression trees.
RESULTS: The AUCs of the MTVs and TLGs for predicting T stage (0.881-0.892) were significantly higher than the AUC of the SUVmax (0.824). In the M stage, the AUCs of MTVs and TLGs (0.688-0.723) were significantly higher than that of the SUVmax (0.606). Recursive partitioning applying classification and regression trees demonstrated that the optimal cutoff values of the most important variables for discriminating T, N, and M stages are MTV2.5 = 9.35 and 63.33 mL, TLG50% = 328.1, and TLG50% = 94.81, respectively.
CONCLUSION: Metabolic tumor volumes and TLGs in PET/CT are reliable diagnostic biomarkers. Using these parameters, more accurate preoperative diagnoses for CRC can be made.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27556789     DOI: 10.1097/RLU.0000000000001332

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  11 in total

1.  PET/MRI Radiomics in Rectal Cancer: a Pilot Study on the Correlation Between PET- and MRI-Derived Image Features with a Clinical Interpretation.

Authors:  Barbara Juarez Amorim; Angel Torrado-Carvajal; Shadi A Esfahani; Sara S Marcos; Mark Vangel; Dan Stein; David Groshar; Onofrio A Catalano
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

2.  Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters.

Authors:  Haejun Lee; Kyung-Hoon Hwang; Kwang An Kwon
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Correlation of 18F-FDG/PET SUVmax, SUVmean, MTV, and TLG with HIF-1α in Patients with Colorectal Cancer

Authors:  Zümrüt Arda Kaymak; Nermin Karahan; Mehmet Erdoğan; Evrim Erdemoğlu; İsmail Zihni; Sevim Süreyya Şengül
Journal:  Mol Imaging Radionucl Ther       Date:  2021-06-03

4.  Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.

Authors:  Jun Huang; Liang Huang; Jiaming Zhou; Yinghua Duan; Zhanwen Zhang; Xiaoyan Wang; Pinzhu Huang; Shuyun Tan; Ping Hu; Jianping Wang; Meijin Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-15       Impact factor: 9.236

5.  Preoperative PET/CT 18F-FDG Standardized Uptake by Lymph Nodes as a Significant Prognostic Factor in Patients with Colorectal Cancer.

Authors:  Ruohua Chen; Yining Wang; Xiang Zhou; Gang Huang; Jianjun Liu
Journal:  Contrast Media Mol Imaging       Date:  2018-11-01       Impact factor: 3.161

6.  Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment.

Authors:  E J van Helden; Y J L Vacher; W N van Wieringen; F H P van Velden; H M W Verheul; O S Hoekstra; R Boellaard; C W Menke-van der Houven van Oordt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-09       Impact factor: 9.236

7.  Predictive Value of Metabolic Parameters Derived From 18F-FDG PET/CT for Microsatellite Instability in Patients With Colorectal Carcinoma.

Authors:  Hao Liu; Zheng Ye; Ting Yang; Hongjun Xie; Ting Duan; Mou Li; Min Wu; Bin Song
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

8.  Prognostic value of metabolic parameters on 18F-fluorodeoxyglucose positron tomography/computed tomography in classical rectal adenocarcinoma.

Authors:  Byung Wook Choi; Sungmin Kang; Sung Uk Bae; Woon Kyung Jeong; Seong Kyu Baek; Bong-Il Song; Kyoung Sook Won; Hae Won Kim
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  Retrospective analysis of the prognostic value of PD-L1 expression and 18F-FDG PET/CT metabolic parameters in colorectal cancer.

Authors:  Hao Jiang; Rongjun Zhang; Huijie Jiang; Mingyu Zhang; Wei Guo; Jifeng Zhang; Xinglu Zhou; Wenbin Pan; Sheng Zhao; Ping Li
Journal:  J Cancer       Date:  2020-02-25       Impact factor: 4.207

10.  FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.

Authors:  Shih-Hsin Chen; Kenneth Miles; Stuart A Taylor; Balaji Ganeshan; Manuel Rodriquez; Francesco Fraioli; Simon Wan; Asim Afaq; Robert Shortman; Darren Walls; Luke Hoy; Raymond Endozo; Aman Bhargava; Matthew Hanson; Joseph Huang; Sherif Raouf; Daren Francis; Shahab Siddiqi; Tan Arulampalam; Bruce Sizer; Michael Machesney; Nicholas Reay-Jones; Sanjay Dindyal; Tony Ng; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.